JULIE JOHNSON, PHARM.D., FCCP

Professor and Chair
Department of Pharmacy Practice
University of Florida

Research Interests
• Cardiovascular pharmacogenetics
• Drug target pharmacogenetics
• Pharmacotherapy of hypertension and heart failure

Areas of Technical Expertise
• Cardiovascular drug therapy
• Pharmacogenetics research
• Pharmacokinetics/pharmacodyanamics/clinical pharmacology

Consulting Expertise
• Pharmacogenetics
• Cardiovascular drugs
• Pharmacokinetics/clinical pharmacology

Selected Publications

1. Johnson J.A., Evans W.E.  “Molecular Diagnostics as a Predictive Tool:  Genetics of Drug Efficacy and Toxicity.”  (Invited review) Trends Mol. Med., 8:300-305 (2002).
2. Evans W.E., Johnson J.A.  “Pharmacogenomics: The Inherited Basis for Inter-individual Differences in Drug Response.”  (Invited review)  Ann. Rev. Genomics Hum. Genet., 2:9-39 (2001).
3. Wang J., Humma L.M., Mougey E.B., David C.J., Johnson J.A., Lima J.J., Sylvester J.E. “Determination of Human b2-adrenergic Receptor Haplotypes by Denaturation Selective Amplification and Subtractive Genotyping.”  Am. J. Pharmacogenom, 1:315-322 (2001).
4. Humma L.M., Puckett B.J., Richardson H.E., Terra S.G., Andrisin T.E., Lejeune B.L., Farmerie W.G., Wallace M.R., Lewis J.F., McNamara D.M., Picoult-Newberg L., Pepine C.J., Johnson J.A.  “Effects of b1-adrenoceptor Genetic Polymorphisms on Resting Hemodynamics in Patients Undergoing Diagnostic Testing for Ischemia.”  Am. J. Cardiol, 88:1034-37 (2001).
5. Johnson J.A.  “Drug Target Pharmacogenomics: An Overview.”  (Invited review).  Am. J. Pharmacogenomics, 1:271-281 (2001).